SARS-CoV-2 nsp13-IN-1
Product Specifications
CAS Number
1005304-44-8
Target
Antiviral|||SARS-CoV
Related Pathways
Immunology/Inflammation|||Microbiology/Virology
Purity
0.9944
Bioactivity
SARS-CoV-2 nsp13-IN-1 (compound C1) is a potent inhibitor of nsp13 (non-structural protein 13), selectively inhibiting nsp13 ssDNA+ATPase with an IC50 of 6 ?M, but not ssDNA-ATPase, and can be used to study COVID-19.
Smiles
CC1=NC2=C(C=CC=N2)C(=O)N1C1=CC=C(NC(=O)C2=CC=C(C=C2)C2=CC=CC=C2)C=C1
Molecular Formula
C27H20N4O2
Molecular Weight
432.47
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Tozasertib, Free Base (N-[4-[[4- (4-methylpiperazin-1-yl) -6-[ (5-methyl-1H-pyrazol-3-yl) amino]pyrimidin-2-yl]sulfanyl]phenyl]cyclopropanecarboxamide, VX-680, MK-0457, VX6)](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
T8078-01 10 mg
Tozasertib, Free Base (N-[4-[[4- (4-methylpiperazin-1-yl) -6-[ (5-methyl-1H-pyrazol-3-yl) amino]pyrimidin-2-yl]sulfanyl]phenyl]cyclopropanecarboxamide, VX-680, MK-0457, VX6)
Ask
View Details T8078-02 25 mg
Tozasertib, Free Base (N-[4-[[4- (4-methylpiperazin-1-yl) -6-[ (5-methyl-1H-pyrazol-3-yl) amino]pyrimidin-2-yl]sulfanyl]phenyl]cyclopropanecarboxamide, VX-680, MK-0457, VX6)
Ask
View Details